Quality of life in adults with brain tumors: Current knowledge and future directions

Neuro-Oncology

Volumn 11, Issue 3, 2009, Pages 330-339

  Liu, Raymond ^a   Page, Margaretta ^a   Solheim, Karla ^a   Fox, Sherry ^b   Chang, Susan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b St Mary's Hospital Richmond   (United States)

Author keywords

Brain tumor; Clinical trial end points; Quality of life; Survivorship; Symptom management

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; DONEPEZIL; METHYLPHENIDATE; MODAFINIL; TEMOZOLOMIDE;

ANOREXIA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DEPRESSION; DRUG EFFECT; FATIGUE; HUMAN; MOOD DISORDER; PARAMETER; QUALITY OF LIFE; REVIEW; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SOCIAL INTERACTION; SYMPTOM; VOMITING;

BRAIN NEOPLASMS; HUMANS; QUALITY OF LIFE;

EID: 67649607204     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2008-093     Document Type: Review

References (97)

1. Cella D, Chang CH, Lai JS, Webster K. Advances in quality of life measurements in oncology patients. Semin Oncol. 2002;29:60-68. (Pubitemid 34686697)
2. Heimans JJ, Taphoorn MJ. Impact of brain tumour treatment on quality of life. J Neurol. 2002;249:955-960. (Pubitemid 35002212)
3. Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncology. 2000;2:221-228.
4. Davies E, Clarke C, Hopkins A. Malignant cerebral glioma - I: survival, disability, and morbidity after radiotherapy. BMJ. 1996;313:1507-1512. (Pubitemid 27016884)
5. Klein M, Taphoorn MJ, Heimans JJ, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19:4037-4047. (Pubitemid 32976690)
6. Brown PD, Ballman KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76:283-291.
7. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys. 2003;55:992-999. (Pubitemid 36287002)
8. Giovagnoli AR, Tamburini M, Boiardi A. Quality of life in brain tumor patients. J Neurooncol. 1996;30:71-80. (Pubitemid 26265772)
9. Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76:562-568. (Pubitemid 40486584)
10. Brown PD, Maurer MJ, Rummans TA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57:495-504. (Pubitemid 41254457)
11. Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 1994;36:48-54. (Pubitemid 24205823)
12. Gustafsson M, Edvardsson T, Ahlstrom G. The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer. 2006;14:1205-1212. (Pubitemid 44800639)
13. Klein M, Engelberts NH, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54:514-520. (Pubitemid 37176548)
14. Laack NN, Brown PD, Ivnik RJ, et al. Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys. 2005;63:1175-1183. (Pubitemid 41505297)
15. Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002;360:1361-1368. (Pubitemid 35341299)
16. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20:2076-2084. (Pubitemid 34408798)
17. Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol. 1997;15:3129-3140. (Pubitemid 27377505)
18. Salo J, Niemela A, Joukamaa M, Koivukangas J. Effect of brain tumour laterality on patients' perceived quality of life. J Neurol Neurosurg Psychiatry. 2002;72:373-377. (Pubitemid 34185209)
19. Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients. Psychooncology. 2002;11:230-238. (Pubitemid 34618588)
20. Taphoorn MJ, Stupp R, Coens C, et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol. 2005;6:937-944. (Pubitemid 41685226)
21. Whitton AC, Rhydderch H, Furlong W, Feeny D, Barr RD. Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer. 1997;80:258-265. (Pubitemid 27282320)
22. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15:1294-1301. (Pubitemid 27167360)
23. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry. 1998;64:581-587. (Pubitemid 28204142)
24. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg. 2005;103:841-847. (Pubitemid 43194578)
25. Kaplan CP, Miner ME. Relationships: importance for patients with cerebral tumours. Brain Inj. 2000;14:251-259. (Pubitemid 30179156)
26. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws eR Jr. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358-367. (Pubitemid 38209404)
27. Arnold SD, Forman LM, Brigidi BD, et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro-Oncology. 2008;10:171-181.
28. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41-49. (Pubitemid 34692613)
29. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry. 2006;21:194-199.
30. Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005;56:1234-1242. (Pubitemid 40770438)
31. Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256:516-521.
32. Whittle IR, Kelly PA. Mechanisms of peritumoural brain dysfunction: metabolic and neuroreceptor findings in striatal C6 glioma. J Clin Neurosci. 2001;8:430-434. (Pubitemid 32843697)
33. Merzak A, Koochekpour S, Fillion MP, Fillion G, Pilkington GJ. Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration. Brain Res 1996;41:1-7. (Pubitemid 26288138)
34. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159-168. (Pubitemid 38229950)
35. Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000;47:324-334. (Pubitemid 32049338)
36. Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-Oncology. 2003;5:89-95. (Pubitemid 36416837)
37. Klein M, Postma TJ, Taphoorn MJ, et al. The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology. 2003;61:1796-1798. (Pubitemid 38020834)
38. Brown PD, Jensen AW, Felten SJ, et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol. 2006;24:5427-5433. (Pubitemid 46623176)
39. Gorlia T, Stupp R, Eisenhauer EA, et al. Clinical prognostic factors affecting survival in patients with newly diagnosed glioblastoma multiforme (GBM) [abstract]. J Clin Oncol. 2004;22:9599.
40. Brown PD, Buckner JC, O'Fallon JR, et al. Importance of baseline Mini-Mental State examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004;59:117-125. (Pubitemid 38501515)
41. Meyers CA, Wefel JS. The use of the Mini-Mental State examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003;21:3557-3558.
42. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg. 1994;80:247-253. (Pubitemid 24036495)
43. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol. 1990;28:818-822.
44. Maire JP, Coudin B, Guerin J, Caudry M. Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol. 1987;10:156-162. (Pubitemid 17055333)
45. Giovagnoli AR. Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour. J Neurol Neurosurg Psychiatry. 1999;67:358-363. (Pubitemid 29392596)
46. Schmidinger M, Linzmayer L, Becherer A, et al. Psychometric- and quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol. 2003;63:55-61. (Pubitemid 36681643)
47. Leibel SA, Gutin PH, Wara WM, et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 1989;17:1129-1139. (Pubitemid 20028628)
48. Scott JN, Rewcastle NB, Brasher PM, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol. 1999;46:183-188. (Pubitemid 29382874)
49. Awwad S, Cull A, Gregor A. Long-term survival in adult hemispheric glioma: prognostic factors and quality of outcome. Clin Oncol (R Coll Radiol). 1990;2:343-346.
50. Steinbach JP, Blaicher HP, Herrlinger U, et al. Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology. 2006;66:239-242. (Pubitemid 43970162)
51. Giovagnoli AR, Boiardi A. Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci. 1994;15:481-488.
52. Rich TA. Symptom clusters in cancer patients and their relation to eGFR ligand modulation of the circadian axis. J Support Oncol. 2007;5:167-174. (Pubitemid 46929228)
53. Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Sch. 2004;36:197-206. (Pubitemid 41725172)
54. Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade glioma. J Nurs Sch. 2007;39:61-67.
55. Taylor BV, Buckner JC, Cascino TL, et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol. 1998;16:2195-2201. (Pubitemid 28265058)
56. Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26:921-925.
57. Shaw EG, Rosdhal R, D'Agostino RB Jr, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006;24:1415-1420.
58. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998;16:2522-2527. (Pubitemid 28309050)
59. Butler JM Jr, Case LD, Atkins J, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d- threomethylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69:1496-1501. (Pubitemid 350116415)
60. Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. J Clin Oncol. 2006;24:1503.
61. Jones LW, Guill B, Keir ST, et al. Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancer. Psychooncology. 2007;16:232-240. (Pubitemid 46380547)
62. Fox S, Laws ER Jr, Anderson F Jr, Farace e. Complementary therapy use and quality of life in persons with high-grade gliomas. J Neurosci Nurs. 2006;38:212-220.
63. Armstrong T, Cohen MZ, Hess KR, et al. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J Pain Symptom Manage. 2006;32:148-154. (Pubitemid 44108587)
64. Willis SL, Tennstedt SL, Marsiske M, et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA. 2006;296:2805-2814. (Pubitemid 44969180)
65. Rogers MP, Orav J, Black PM. The use of a simple Likert scale to measure quality of life in brain tumor patients. J Neurooncol. 2001;55:121-131. (Pubitemid 34065328)
66. Pringle AM, Taylor R, Whittle IR. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg. 1999;13:46-51. (Pubitemid 29139948)
67. Mainio A, Hakko H, Niemela A, Tuurinkoski T, Koivukangas J, Rasanen P. The effect of brain tumour laterality on anxiety levels among neurosurgical patients. J Neurol Neurosurg Psychiatry. 2003;74:1278-1282. (Pubitemid 37152258)
68. Cummings JL. Neuropsychiatric manifestations of right hemisphere lesions. Brain Lang. 1997;57:22-37. (Pubitemid 27187889)
69. Irle E, Peper M, Wowra B, Kunze S. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol. 1994;51:164-174. (Pubitemid 24051580)
70. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol. 1996;30:61-69. (Pubitemid 26265771)
71. Kaleita TA, Wellisch DK, Cloughesy TF, et al. Prediction of neurocognitive outcome in adult brain tumor patients. J Neurooncol. 2004;67:245-253. (Pubitemid 38418276)
72. Anderson SW, Damasio H, Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol. 1990;47:397-405. (Pubitemid 20132142)
73. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 1994;12:627-642. (Pubitemid 24079908)
74. Gregor A, Cull A, Traynor E, Stewart M, Lander F, Love S. Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol. 1996;41:55-59. (Pubitemid 26396297)
75. Brown PD, Buckner JC, O'Fallon JR, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State examination. J Clin Oncol. 2003;21:2519-2524. (Pubitemid 46606333)
76. Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer. 1998;34:1902-1909. (Pubitemid 28535439)
77. Surma-aho O, Niemela M, Vilkki J, et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 2001;56:1285-1290. (Pubitemid 32455284)
78. Osoba D, Brada M, Yung WK, Prados MD. Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. Eur J Cancer. 2000;36:1788-1795. (Pubitemid 30639499)
79. Meador KJ. Cognitive side effects of medications. Neurol Clin. 1998;16:141-155. (Pubitemid 28081035)
80. Carson KA, Grossman SA, Fisher JD, Shaw eG. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol. 2007;25:2601-2606. (Pubitemid 47041234)
81. Lovely MP. Quality of life of brain tumor patients. Semin Oncol Nurs. 1998;14:73-80.
82. Sachsenheimer W, Piotrowski W, Bimmler T. Quality of life in patients with intracranial tumors on the basis of Karnofsky's Performance Status. J Neurooncol. 1992;13:177-181.
83. Mackworth N, Fobair P, Prados MD. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol. 1992;14:243-253. (Pubitemid 23012159)
84. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53:2002-2007. (Pubitemid 14127662)
85. Recht L, Glantz M, Chamberlain M, Hsieh CC. Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. J Neurooncol. 2003;61:127-136. (Pubitemid 36253658)
86. Osoba D, Aaronson NK, Muller M, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996;5:139-150. (Pubitemid 26100512)
87. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75:1151-1161.
88. Locke DE, Decker PA, Sloan JA, et al. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage. 2007;34:628-638. (Pubitemid 350161248)
89. Armstrong TS, Mendoza T, Gning I, et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006;80:27-35. (Pubitemid 44473259)
90. Lyons GJ. The "PReSTON Profile" - the first disease-specific tool for assessing quality of life in patients with malignant glioma. Disabil Rehabil. 1996;18:460-468. (Pubitemid 26315695)
91. Meyers CA, Hess KR, Yung WK, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000;18:646-650. (Pubitemid 30078546)
92. Walker M, Brown J, Brown K, Gregor A, Whittle IR, Grant R. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol. 2003;63:179-186. (Pubitemid 36705687)
93. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res. 2006;15:1533-1550. (Pubitemid 44736786)
94. Efficace F, Bottomley A. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer. 2002;38:1824-1831. (Pubitemid 35247467)
95. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26:1355-1363.
96. Mauer ME, Taphoorn MJ, Bottomley A, et al. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol. 2007;25:5731-5737.
97. McCarter H, Furlong W, Whitton AC, et al. Health status measurements at diagnosis as predictors of survival among adults with brain tumors. J Clin Oncol. 2006;24:3636-3643. (Pubitemid 46630538)